期刊文献+

MRI、MDCT检测肾癌下腔静脉癌栓及癌栓侵犯血管壁价值的系统评价 被引量:5

Value of MRI and MDCT in Detecting Both Inferior Vena Cava Tumor Thrombus and Vena Cava Wall Invasion in Renal Cell Carcinoma: A Systematic Review
原文传递
导出
摘要 目的对MRI、MDCT检测下腔静脉癌栓及癌栓侵犯血管壁的价值进行系统评价。方法计算机检索PubMed、EMbase、Cochrane图书馆、MELINE(Ovid)、CBM、CNKI、VIP及WanFang Data的相关英文及中文文献,检索时限为2000年1月~2012年2月。按照纳入和排除标准选择文献、提取资料和评价纳入研究的方法学质量后,采用RevMan 5、Meta-disc 1.4软件对纳入文献进行异质性检验及Meta分析。结果共纳入6篇文献,244例患者,246例肾癌。Meta分析结果显示:MRI和MDCT组的敏感度分别为0.963、0.952,特异度分别为0.969、0.979,+LR分别为9.759、15.57,–LR分别为0.091、0.108,dOR分别为198.71、251.54。各组合并效应量间均无统计学差异(P>0.05)。MDCT组的SROC曲线下面积(AUC)为0.981 8,Q*0.940 7。结论 MRI与MDCT诊断肾癌下腔静脉癌栓的差异无统计学意义。由于现有资料有限,今后还应更多地进行关于癌栓侵犯血管壁的原始研究。 Objective To evaluate the value of MRI and MDCT in detecting both inferior vena cava tumor thrombus and vena cava wall invasion in renal cell carcinoma. Methods Databases including PubMed, EMbase, The Cochrane Library, MEDLINE (Ovid), CBM, CNKI, VIP and WanFang Data were searched from January 2000 to February 2012. Relevant studies were screened on the basis of the inclusion and exclusion criteria, and then quality assessment and data extraction were conducted. Then heterogeneity test and meta-analysis were conducted using RevMan 5 and Meta-disc 1.4. Results A total of 6 trials involving 244 patients and 246 cases of renal cell carcinoma were included. The results of meta-analysis showed that, for the MRI group and the MDCT group, the sensitivity was 0.963 and 0.952, the specificity was 0.969 and 0.979, the value of +LR was 9.759 and 15.57, the value of -LR was 0.091 and 0.108, and the dOR was 198.71 and 251.54, respectively. There were no significant differences in pooled effect-size among groups (P〉0.05). The area un- der curve (AUC) of summary ROC curve analysis as well as Q^* index of the MDCT group were 0.981 8 and 0.940 7, respectively. Conclusion There is no significant difference in the value of MRI and MDCT in detecting inferior vena cava tumor thrombus induced by renal cell carcinoma. More original studies on vena cava wall invasion by tumor thrombus should be conducted in the future due to the limitation of current materials.
出处 《中国循证医学杂志》 CSCD 2013年第1期21-25,共5页 Chinese Journal of Evidence-based Medicine
关键词 肾肿瘤 癌栓 下腔静脉 MRI MDCT 系统评价 Renal cell carcinoma Tumor thrombus Inferior vena cava MRI MDCT Systematic review
  • 相关文献

参考文献1

二级参考文献30

  • 1Kabala JE. The kidneys and ureters. In: Sutton D, ed. Textbook of radiology and imaging. Churchill Livingstone: London; 2003: 953.
  • 2Kearney GP, Waters WB, Klein LA, Richie JR Gittes RF. Results of inferior vena cava resection for renal cell carcinoma. J Urol 1981; 125: 769-773.
  • 3Russo P. Renal cell carcinoma: presentation, staging and surgical treatment. Semin Oncol 2000; 27: 160-176.
  • 4Figlin RA. Renal cell carcinoma: management of advanced disease. J Urol 1999; 161: 381-386.
  • 5Sheth S, Scatarige J, Horton K, Cod FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: Role of multidetector CT and three dimensional CT. Radiographics 2001; 21: s237-s254.
  • 6Staehler G, Brkovic D. The role of radical surgery for renal cell carcinoma with extension into the vena cava. J Urol 2000; 163: 1671-1675.
  • 7Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004; 94: 33-41.
  • 8Hoehn W, Hermanek E Invasion of veins in renal cell carcinoma frequency, correlation and prognosis. Eur Urol 1983; 9: 276-280.
  • 9Novick AC, Cosgrove DM. Surgical approach for removal of renal cell carcinoma extending into the vena cava and the right atrium. J Urol 1980; 123: 947-950.
  • 10Pritchett TR, Lieskovsky G, Skinner DG. Extension of renal cell carcinoma into the vena cava: clinical review and surgical approach. J Urol 1986; 135: 460-464.

共引文献10

同被引文献53

  • 1韩希年,彭令荣,刘光华,王俭.100例小肾癌螺旋CT多期扫描分析[J].中华肿瘤杂志,2007,29(5):382-385. 被引量:20
  • 2郁成,陈永强,罗泽斌.乏脂肪肾血管平滑肌脂肪瘤与肾细胞癌的CT鉴别诊断[J].临床放射学杂志,2007,26(11):1119-1121. 被引量:30
  • 3Volpe A,Patard JJ. Prognostic factors in renal cell carcinoma [ J].World J Urol,2010,28(3) :319,327.
  • 4Edge SB,Byrd DR,Compton CC,et al. AJCC cancer staging manual[M]. 7th ed. New York:Springer,2010 :480-488.
  • 5Bata P,Gyebnar J,Tamoki DL,et al. Clear cell renal cell carcinomaand papillary renal cell carcinoma: differentiation of distinct histologi-cal types with multiphase CT[ J] . Diagn Interv Radiol,2013 ,19(5):387-392.
  • 6Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
  • 7Bhatt JR, Finelli A. Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat Rev Urol, 2014, 11(9): 517-525.
  • 8Brocato J, Chervona Y, Costa M. Molecular responses to hypoxia-inducible factor 1alpha and beyond. Mol Pharmacol, 2014, 85(5): 651-657.
  • 9Rohwer N, Zasada C, Kempa S, et al. The growing complexity of HIF-1alpha's role in tumorigenesis: DNA repair and beyond. Oncogene, 2013, 32(31): 3569-3576.
  • 10Medina V, Aparicio G, Santamarina CI, et al. Searching for Hif1-alpha interacting proteins in renal cell carcinoma. Clin Transl Oncol, 2012, 14(9): 698-708.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部